| Title: | Identification of genetic components underlying cerebrovascular diseases and their related outcomes |
| Lead Institution: | Massachusetts General Hospital |
| Principal investigator: | Dr Christopher Anderson |
Application 36993
WARNING: the interactive features of this website use CSS3, which your browser does not support. To use the full features of this website, please update your browser.
About
Aim: The main aim of our study is to do genetic association study with stroke in order to identify its genetic risk factors. Rationale: Genetics is such a powerful tool for identifying disease etiology. We will understand key mechanism of stroke based on the findings from this proposed genetic study. Duration: This study will take 3 years. Impact: Better understanding stroke mechanism by genetics provides promising grounds for implications for clinical practice and development of therapeutic approaches for the disease.3 Publications
| Pub ID | Title | Author(s) | Year | Journal |
|---|---|---|---|---|
| 11100 | A Genomic Risk Score Identifies Individuals at High Risk for Intracerebral Hemorrhage | Evangelos Pavlos Myserlis (+12) | 2023 | Stroke |
| 7949 | Genetic Risk Score Improves Risk Stratification for Anticoagulation-Related Intracerebral Hemorrhage | Ernst Mayerhofer (+6) | 2023 | Stroke |
| 9382 | Genetic and Nongenetic Components of Stroke Family History: A Population Study of Adopted and Nonadopted Individuals | Ernst Mayerhofer (+6) | 2023 | Journal of the American Heart Association |
Enabling scientific discoveries that improve human health